您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > 4-iodo-SAHA
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
4-iodo-SAHA
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
4-iodo-SAHA图片
CAS NO:1219807-87-0
包装与价格:
包装价格(元)
100mg电议
250mg电议
500mg电议

产品名称
ISAHA
产品介绍
4-Iodo-SAHA (1k) 是一种 I 类和 II 类histone deacetylase (HDAC)的抑制剂,对 Skbr3、HT29、U937、JA16 和 HL60 细胞的EC50值分别为 1.1、0.95、0.12、0.24、0.85 和 1.3 μM。4-Iodo-SAHA 可用于癌症的研究。
生物活性

4-Iodo-SAHA (1k) is an orally active class I and class IIhistone deacetylase (HDAC)inhibitor withEC50s of 1.1, 0.95, 0.12, 0.24, 0.85 and 1.3 μM for Skbr3, HT29, U937, JA16 and HL60 cell lines, respectively. 4-Iodo-SAHA (1k) can be used for the research ofcancer[1].

体外研究
(In Vitro)

4-Iodo-SAHA (0.1-100 μM; 48 h) inhibits Skbr3, HT29, U937, JA16 and HL60 cell lines[1].
4-Iodo-SAHA (2 μM; 6-24 h) affects acetylated H4 and p21 levels in SKBR3 cells[1].

Cell Proliferation Assay[1]

Cell Line:SKBR3, HT29, U937, JA16 and HL60 cell lines
Concentration:0.1-100 μM
Incubation Time:48 h
Result:Inhibited SKBR3, HT29, U937, JA16 and HL60 cell lines withEC50s of 1.1, 0.95, 0.12, 0.24, 0.85 and 1.3 μM , respectively. Showed 10-fold potent as an inhibitor of U937 cell line compared to SAHA.

Western Blot Analysis[1]

Cell Line:SKBR3-breast-derived cell line
Concentration:2 μM
Incubation Time:6, 12 and 24 h
Result:Time-dependently up regulated histone H4 acetylation and p21/WAF1 cell cycle inhibitor accumulation in SKBR3 cells.
体内研究
(In Vivo)

4-Iodo-SAHA (1k) (50 mg/kg; p.o. five times a week for two weeks) compares to SAHA-treated and control mice with similar toxicity[1].

Animal Model:8-week-old fvb mice[1]
Dosage:50 mg/kg
Administration:Oral gavage; 50 mg/kg five times per week; for 2 weeks
Result:Compared to both SAHA-treated and control mice with similar body weights and hematological counts.
分子量

390.22

Formula

C14H19IN2O3

CAS 号

1219807-87-0

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.